Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
4 competitors in Chronic Graft-versus-host-disease
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Rezurock
Treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy.
Influenza (Healthy Volunteers)
Type 2 Diabetes Mellitus
Diphtheria
Non Small Cell Lung Cancer
Influenza